BioCentury
ARTICLE | Clinical News

Elobixibat: Phase III data

October 10, 2016 7:00 AM UTC

Top-line data from a double-blind, Japanese Phase III trial in patients with chronic constipation showed that elobixibat for 14 days met the primary endpoint of improving the number of weekly SBMs fro...